KU Leuven spin-off AstriVax raises €30m to build vaccine platform
Closing on €30m, vaccine producer, AstriVax, has raised the largest amount of seed capital in the history of KU Leuven spin-offs.
Archives for August 25, 2022
Novartis is spinning off its Sandoz business
The Swiss pharma giant wants to turn its biosimilar and generics division into a standalone company.
AskBio subsidiary readies to start clinical trials for Huntington’s Disease gene therapy
BrainVectis, a subsidiary of AskBio, has received clearance from the French authorities to start a Phase 1-2 clinical trial for its novel Huntington’s Disease gene therapy, BV-101.
WHO recommends two mAbs in fight against Ebola
The World Health Organization (WHO) has published its first guidelines for Ebola virus disease therapeutics, issuing ‘strong recommendations’ for the use of two monoclonal antibodies.